홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
SNDX
#1700
Syndax Pharmaceuticals, Inc.
21.7
1
+6.89%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+6.89%
월간 변동
+1.92%
6달 변화
+32.54%
년간 변동율
+43.02%
이전 종가
20.3
1
Open
21.7
1
Bid
Ask
Low
21.7
1
High
21.7
1
양
124
마켓
주식
헬스케어
SNDX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
48.24 M
55.01 M
68.44 K
84.97 M
86.02 M
88.2 M
—
Valuation ratios
Enterprise value
957.52 M
982.25 M
-72.6 M
1.56 B
983.16 M
1.72 B
4.54 B
Price to earnings ratio
—
47.59
-10.41
-7.34
-3.55
-6.39
-16.26
Price to sales ratio
—
8.4
—
—
47.8
—
—
Price to cash flow ratio
—
40.29
-11.64
-9.58
-4.12
5.64
-4.96
Price to book ratio
—
2.87
3.33
2.78
3.93
28.16
31.45
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.24
0.06
0.3
0.34
0.44
0.54
0.49
Return on equity %
0.29
0.06
0.32
0.38
1.11
4.42
2.43
Return on invested capital %
2 493.6
929.46
4 423.93
2 612.85
1 177.24
746.06
792.31
Gross margin %
100
100
—
—
100
97.87
400
Operating margin %
4 708.17
18.77
—
—
1 434.43
158.45
817.14
EBITDA margin %
—
—
—
—
—
-163.2
—
Net margin %
4 822.54
17.84
—
—
1 346.11
165.6
844.3
Liquidity ratios
Quick ratio
—
—
—
—
5.82
4.12
18.85
Current ratio
15.84
21.68
16.85
10
5.82
4.4
19.55
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.37
0
0
0.04
0.27
0.3
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.06
0.04
0
—
0.46
-0.01
-0.04
Long term debt to total equity ratio
0.07
0.05
0
—
1.15
-0.09
-0.21
Per share metrics
Operating cash flow per share
—
0.54
2.2
2.28
3.21
3.73
3.74
EBIT per share
—
—
—
—
—
-3.19
—
EBITDA per share
—
—
—
—
—
-3.25
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
8.2
7.83
8.11
6.69
4.55
20.8
Net current asset value per share
—
8.36
8.06
8.25
7.04
6.1
24.74
Tangible book value per share
—
7.62
7.69
7.88
3.37
0.75
6.4
Working capital per share
—
7.98
7.58
7.43
5.83
4.71
19.63
Book value per share
—
7.62
7.69
7.88
3.37
0.75
6.4
뉴스
Stifel, Syndax Pharmaceuticals 목표 주가 상향
Stifel raises Syndax Pharmaceuticals stock price target on drug sales
Syndax Pharmaceuticals, Inc. (SNDX) Q4 2025 Earnings Call Transcript
Syndax 2025년 4분기 실적 발표: 매출 50% 급증, 수익성 경로 제시
Syndax Q4 2025 slides: revenue surges 50%, profitability path outlined
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
Syndax Pharmaceuticals Q4 실적 에상치보다 저조, 수익 예상치를 넘어
Syndax Pharmaceuticals earnings missed by $0.19, revenue topped estimates
Syndax, 암 치료제 출시 가속화 속 실적 시험대
Syndax faces earnings test as cancer drug launches accelerate
Syndax, Guggenheim 서밋에서 강력한 성장과 전략적 확장 강조
Syndax Pharmaceuticals' Early Launch Success Signals Continued Growth Into 2026 (NASDAQ:SNDX)